Drug Discovery & Designing

Drug design, sometimes referred to as rational drug design or simply rational design, is the inventive process of finding new medications based on the knowledge of a biological target. The drug is most commonly an organic small molecule that activates or inhibits the function of a biomolecule such as a protein, which in turn results in a therapeutic benefit to the patient. In the most basic sense, Pharmaceutical drug design involves the Drug design of molecules that are complementary in shape and charge to the bimolecular target with which they interact and therefore will bind to it. Molecular Drug design frequently but not necessarily relies on computer modelling technique. Drug discovery is the process by which new candidate medications are discovered. Historically, drugs were discovered through identifying the active ingredient from traditional remedies or by serendipitous discovery.

The global market for drug discovery technologies reached nearly $39.5 billion and $46.5 billion in 2013 and 2014, respectively. This market is expected to grow at a compound annual growth rate (CAGR) of 11.3% to nearly $79.5 billion for the period 2014-2019. Analyses of global market trends, with data from 2012-2014, and projections of CAGRs through 2019.A look at the current state of the drug discovery market, existing platforms and products on the market, and detailed analysis of the competitive environments including new, potential venues for novel technologies and approaches. Descriptions of various products such as bioanalytical instruments, high-throughput screening devices, informatics, and microarrays. Analyses of the main positive and negative factors in each sector of the market, potential future trends, and emerging technologies across different segments of the industry.

  • Recent advances in computer aided drug design

Related Conference of Drug Discovery & Designing

Drug Discovery & Designing Conference Speakers